🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT04577248
Recruiting Observational

The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry

NCT04577248 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2020-09-15
Last updated
2020-10-08

Condition(s) studied

Mitral Valve RegurgitationMitral Valve StenosisTricuspid Valve Regurgitation

Investigational drug(s) / intervention(s)

edge-to-edge valve repair

edge-to-edge valve repair: edge-to-edge valve repair

Study summary

Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.

Eligibility

Sex
ALL
Min age
18 Years
Max age
110 Years
Healthy volunteers
No
Inclusion Criteria: * Age above 18 years and consentable * Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis * Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision * Written informed consent Exclusion Criteria: * Patient's inability to fully cooperate with the protocol

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München Munich Bavaria Recruiting

More Deutsches Herzzentrum Muenchen trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04577248 on ClinicalTrials.gov ↗ ← All trials in Germany